Polio and the risk for the European Union

Affiliations

¹ European Centre for Disease Prevention and Control, Stockholm SE-171 83, Sweden. Electronic address: lucia.pastore.celentano@ecdc.europa.eu.
² European Centre for Disease Prevention and Control, Stockholm SE-171 83, Sweden.

Comment

Lucia Pastore Celentano et al. Lancet. 2014.

. 2014 Jan 18;383(9913):216-7.

doi: 10.1016/S0140-6736(13)62223-0. Epub 2013 Nov 14.

¹ European Centre for Disease Prevention and Control, Stockholm SE-171 83, Sweden. Electronic address: lucia.pastore.celentano@ecdc.europa.eu.
² European Centre for Disease Prevention and Control, Stockholm SE-171 83, Sweden.

No abstract available

Comment in

Should we use oral polio vaccine in Europe?
Lycke E, Magnius LO, Norder H. Lycke E, et al. Lancet. 2014 Mar 22;383(9922):1037-8. doi: 10.1016/S0140-6736(14)60514-6. Lancet. 2014. PMID: 24656196 No abstract available.
Should we use oral polio vaccine in Europe? - Authors' reply.
Bancroft EA, Carrillo-Santisvere P, Celentano LP, Danielsson N, Giesecke J. Bancroft EA, et al. Lancet. 2014 Mar 22;383(9922):1038-9. doi: 10.1016/S0140-6736(14)60515-8. Lancet. 2014. PMID: 24656197 No abstract available.

Polio emergence in Syria and Israel endangers Europe.
Eichner M, Brockmann SO. Eichner M, et al. Lancet. 2013 Nov 30;382(9907):1777. doi: 10.1016/S0140-6736(13)62220-5. Epub 2013 Nov 8. Lancet. 2013. PMID: 24211043 No abstract available.